Moderna to Provide Business and Pipeline Updates at the 2023 J.P. Morgan Healthcare Conference

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/1/2026

1. NKE
2. TSLA
3. SPY
4. NVDA
5. BE
6. SPCX
7. META
8. ABVX
9. STZ
10. MU

Go back to Moderna to Provide Business and Pipeline Updates at the 2023 J.P. Morgan Healthcare Conference

Morgan Stanley Calls Moderna (MRNA) a Catalyst Driven Idea

January 5, 2023 4:09 PM EST

Morgan Stanley analyst Matthew Harrison reiterated an Equalweight rating and $209.00 price target on Moderna (NASDAQ: MRNA).

The analyst comments "We expect the first interim analysis from Moderna's Ph3 RSV vaccine study in the near-term. We believe efficacy and safety in-between... More